[Hormone therapy for ophthalmoprophylaxis]

Area of Science:

• Ophthalmology
• Endocrinology
• Gerontology

Context:

• Hormone replacement therapy (HRT) demonstrates vascular and neuroprotective effects when initiated post-menopause.
• Previous research suggests potential benefits of HRT for ocular health.
• This study investigates the association between HRT and eye health indicators in menopausal women.

Purpose:

• To explore the relationship between hormone replacement therapy (HRT) and visual acuity.
• To assess the correlation between HRT use and intraocular pressure (IOP) in menopausal women.
• To evaluate the potential of HRT as an ophthalmoprophylactic measure.

Summary:

• The study analyzed data from 402 women regarding their menopausal age, HRT use, visual acuity, and intraocular pressure.
• Findings indicate that women aged up to 60 using HRT for over 5 years exhibited better visual acuity (visus > 0.7) and a lower incidence of elevated IOP (above 19 mmHg) compared to non-HRT users.
• Women over 70 with age-related eye conditions rarely used HRT, suggesting the benefits are more pronounced when initiated earlier.

Impact:

• Early initiation of HRT post-menopause may offer protective effects for ocular health, including improved visual acuity and IOP management.
• The findings support the hypothesis that HRT could serve as an ophthalmoprophylactic strategy.
• Further prospective studies with control groups are recommended to confirm these potential benefits of HRT for eye health.